The Clinical Research and Registries Division supports diverse research initiatives in IR. Clinical research involves the investigation of a drug, device, or procedure on a specific population to evaluate the effects on health outcomes. The results can be applied to improve patient care and advance medical knowledge. Investigators are encouraged to participate in research studies on critical topics in IR.
In addition to conducting trials, this division organizes research consensus panel (RCP) meetings and research summits to discuss research priorities in IR and determine how SIR Foundation can support these initiatives. The lead investigator coordinates a panel of multi-disciplinary subject matter experts in the topic's field. The highest research topic is selected for further investigation. Previous participants include representatives from medical institutions, academia, industry, and federal agencies.
Uterine Fibroid Symptom Health- Related Quality of Life Questionnaire (UFS-QOL)
The UFS-QOL is a tool was developed through a grant provided by SIR Foundation by past SIR President James B. Spies, MD, MPH, FSIR, in conjunction with the RAND Corporation. It is specifically designed to assess the symptoms associated with uterine fibroid tumors and is currently in use by several research groups.
If you are interested in reqesting the use of the UFS-QOL for research, please click here.
Research Consensus Panels (RCPs) and Research Summits
Research consensus panels (RCPs) and research summits are multi-disciplinary meetings to discuss critical research areas in IR and determine how the priority topic can be further developed. Research ideas are collected from membership, corporate, and the SIR Service Line Advisory Board (SLAB) as topics to discuss at future RCPs. With the guidance of the SIR Foundation Leadership, the SIR Payment Research and Policy (PReP) Task Force chooses a topic and a lead investigator based on background knowledge in that selected topic. The lead investigator coordinates a panel of multi-disciplinary subject matter experts. The panel then determines two to three top clinical research priority topics that may be developed into a clinical research project. Prioritization will be dependent on the level of innovation and its potential importance to clinical practice and overall global healthcare. Representatives from academia, industry, and federal agencies may be invited as audience members to contribute to the discussion.
- RCP on Lymphatics will be led by Maxim Itkin, MD, FSIR, from University of Pennsylvania Medical Center
- RCP on Bariatric Therapies will be led by Clifford R. Weiss, MD, FSIR, from Johns Hopkins University
Our previous RCP topics can be found here.
Each year, SIR Foundation produces a list of top research priorities, which will be the focus of upcoming research meetings and projects. SIR Foundation asks for research priorities that are most important and/or where additional research is needed in IR, including clinical and non-clinical topics. This list is then considered by leadership, and priorities are set to guide the research agenda for the coming year. This process allows SIR Foundation to make the best use of their resources and to address the issues of highest importance to our membership, patients, corporate partners, policymakers, and the specialty as a whole.
For more information about our current research topics, please visit Research Prioritization
If you have any questions or would like more information about these clinical research program, please contact the Director of Clinical Research and Grants.